TP53 and melanoma: Invasive primary melanomas and advanced stages display additional alterations in pathways involved in the replicative lifespan (TERT promoter), cell cycle control (CDKN2A), cell identity (ARID2), growth and metabolism (PTEN), and resistance to apoptosis (TP53) [4].